Postinflammatory hyperpigmentation: etiologic and therapeutic considerations.
about
S-(-)-10,11-dihydroxyfarnesoic acid methyl ester inhibits melanin synthesis in murine melanocyte cells.Empirical treatment of highly suspected nontuberculous mycobacteria infections following aesthetic procedures.A focused review on acne-induced and aesthetic procedure-related postinflammatory hyperpigmentation in Asians.Lasers and laser-like devices: part two.Refractory Postinflammatory Hyperpigmentation Treated Fractional CO2 LaserCombined treatment with 578-/511-nm copper bromide laser and light-emitting diodes for post-laser pigmentation: a report of two cases.Efficacy and Safety of Clindamycin Phosphate 1.2% and Tretinoin 0.025% Gel for the Treatment of Acne and Acne-induced Post-inflammatory Hyperpigmentation in Patients with Skin of ColorPostinflammatory hyperpigmentation associated with treatment of solar lentigines using a Q-Switched 532-nm Nd: YAG laser: a multicenter survey.Topical niacinamide 4% and desonide 0.05% for treatment of axillary hyperpigmentation: a randomized, double-blind, placebo-controlled studySkin Hyperpigmentation in Indian Population: Insights and Best Practice.Hydroxychloroquine-associated hyperpigmentation mimicking elder abuse.An integral topical gel for cellulite reduction: results from a double-blind, randomized, placebo-controlled evaluation of efficacy.Postinflammatory hyperpigmentation secondary to external insult: an overview of the quantitative analysis of pigmentation.Tinea versicolor in dark-skinned individuals.Recent progress in melasma pathogenesis.Fifty years of research and development of cosmeceuticals: a contemporary review.The melanogenesis-inhibitory effect and the percutaneous formulation of ginsenoside Rb1Anti-inflammatory effects of arbutin in lipopolysaccharide-stimulated BV2 microglial cells.18ß-glycyrrhetinic acid derivative promotes proliferation, migration and aquaporin-3 expression in human dermal fibroblasts.Postinflammatory hyperpigmentation after skin prick testingThe spectrum of skin diseases in a black population in Durban, KwaZulu-Natal, South Africa.Two histopathological patterns of postinflammatory hyperpigmentation: epidermal and dermal.Characteristics of Medical Liability Claims Against Dermatologists From 1991 Through 2015.Hyperpigmentation of the hard palate mucosa in a patient with chronic myeloid leukaemia taking imatinib.Complications and posttreatment care following invasive laser skin resurfacing: A review.Postinflammatory Hyperpigmentation: Epidemiology, Clinical Presentation, Pathogenesis and Treatment.Non-invasive high-intensity focused ultrasound for UV-induced hyperpigmentation in Fitzpatrick skin types III and IV: a prospective, randomized, controlled, evaluator-blinded trial.[Dermoscopically conspiciuous pigmented lesion on the forehead of a young male patient].Ethnopharmacological Approaches for Dementia Therapy and Significance of Natural Products and Herbal Drugs.The assessment of the effect of a cosmetic product brightening the skin of people with discolorations of different etiology.Characterisation of epidermal regeneration in vivo: a 60-day follow-up study.Arsenic-mediated hyperpigmentation in skin via NF-kappa B/endothelin-1 signaling in an originally developed hairless mouse model.Are Natural Ingredients Effective in the Management of Hyperpigmentation? A Systematic Review.The impact of acne and facial post-inflammatory hyperpigmentation on quality of life and self-esteem of newly admitted Nigerian undergraduates.
P2860
Q34072508-3AA1B9A5-5A5C-45A2-8196-C9A4B9EC7FEAQ34492294-5056251E-27A6-42E4-8DAE-74420BCCCA82Q34498211-5C34905B-36E3-44D9-8DC5-1CC8A07B8C91Q35085417-BEFEC229-9C98-4A71-8CE4-02FE9C6F158BQ35136543-9BEC252C-32A1-4D7A-ABD0-7F3AA4633CF8Q35139751-D5B03DBF-D89E-4F14-A5BC-EB6752CD24CAQ36094055-DF73916F-4CC5-4E95-977C-5AB8C45E7397Q36175736-7535463D-5905-4F53-9A9C-4C4088A42759Q36555108-C78C5995-FE48-4FC5-96F2-6B7FEAB768DCQ37268284-60B7C6ED-966F-429F-9C70-387B8569A9AFQ37468370-A4431F29-6578-4A32-9ED2-E765B2E7BBCFQ37600489-C766DD8C-5553-4D59-A3A5-19009E3DA55EQ38016198-1C52F2EE-66C7-4D53-B5CD-A4B91E9B6341Q38169760-A7AD43E1-BF49-49A1-B898-1C814369130CQ38558367-70912B1C-7D77-4530-B4F5-1F3EF22A585EQ38920203-140C351A-59DD-459E-A902-AA76D91C0ABEQ38988497-DF12305F-1F32-4528-9F58-690BC652B997Q39367370-4AC5690C-07E6-44AB-B891-BDB7F61197A5Q41433024-DEBD8500-3244-4497-84D2-B97C7ED1E2B6Q41498506-31D69D33-DDA7-4525-8F90-D8638984FBF7Q42219121-7E6C3353-E97B-48FD-88BE-2E281336A88EQ42500819-DF5C0915-104A-4654-BBCA-024FFB85FFBCQ45951424-385C3707-5DEE-4DC0-9E9B-A75FAFFD2049Q47121694-F5C3165D-6F6B-45F8-8E48-08DAA1555EABQ47784073-C64E37AC-F846-4664-93F1-96F29320ECA9Q48046818-54D12465-F7AF-4001-A9D7-13E408331C8AQ48048037-C60417B9-FB4C-4076-A472-5E4681274E07Q49567852-7B9EC4C7-D64A-4D6D-A560-E783EE9D4C03Q50326656-8F56F54C-8C39-442A-A1A9-870E68B81860Q51678116-0D3F5F9D-31CB-4008-A917-3175773DD8C9Q52882906-7670C7FD-A8D6-4C82-AD2B-1B66524F3FEBQ53314782-42C474FD-4131-42EB-AD40-1CE09EE405CCQ54955410-8B62988B-69CF-49C6-BACC-780D7409C4D3Q55035373-A5A07F8A-64AB-4A91-9C53-D73A3D7AD990
P2860
Postinflammatory hyperpigmentation: etiologic and therapeutic considerations.
description
2011 nî lūn-bûn
@nan
2011 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Postinflammatory hyperpigmentation: etiologic and therapeutic considerations.
@ast
Postinflammatory hyperpigmentation: etiologic and therapeutic considerations.
@en
type
label
Postinflammatory hyperpigmentation: etiologic and therapeutic considerations.
@ast
Postinflammatory hyperpigmentation: etiologic and therapeutic considerations.
@en
prefLabel
Postinflammatory hyperpigmentation: etiologic and therapeutic considerations.
@ast
Postinflammatory hyperpigmentation: etiologic and therapeutic considerations.
@en
P2093
P2860
P1476
Postinflammatory hyperpigmentation: etiologic and therapeutic considerations.
@en
P2093
Erica C Davis
Marissa Maclin
Sharleen St Surin-Lord
Valerie D Callender
P2860
P356
10.2165/11536930-000000000-00000
P577
2011-04-01T00:00:00Z
P6179
1024977103